New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2014
07:15 EDTICPTIntercept shares should be bought amid biotech weakness, says Oppenheimer
After meeting with Intercept's management, Oppenheimer believes that the company's management successfully explained issues involving OCA lipids, and the firm is now more confident in the company's ability to deal with future regulatory uncertainties. Oppenheimer keeps an Outperform rating on the stock.
News For ICPT From The Last 14 Days
Check below for free stories on ICPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2014
08:59 EDTICPTOn The Fly: Pre-market Movers
Subscribe for More Information
April 12, 2014
20:04 EDTICPTIntercept reports additional positive data from POISE trial at EASL
Subscribe for More Information
April 11, 2014
09:08 EDTICPTIntercept announces OCA preclinical study data
Subscribe for More Information
April 9, 2014
07:23 EDTICPTEuropean Association for the Study of the Liver to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use